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Abstract
Background: The burden of neurological diseases is increasing in developing countries. However, there is a
prominent scarcity of literature on the incidence of neurological diseases in sub-Saharan Africa. This study was
therefore undertaken to determine the prevalence and incidence of neurological diseases in this setting to serve as
a baseline for planning and care for neurological disorders in Uganda.
Methods: The study was conducted within rural and urban Mukono district, east of Kampala city of Uganda, central
region. Over a period of six months, a cross sectional survey was conducted and screening was performed using a
standardized questionnaire. All subjects with neurological symptoms and signs were reviewed by a team of
neurologists and neurological diagnoses made.
Results: Of the 3000 study subjects, 50.3% (1510/3000) were from the rural setting. Out of the participants
screened, 67.4% were female, with a median age of 33 years. Among the 98 subjects with confirmed neurological
disorders, the frequency of diseases was as follows; peripheral neuropathy (46.2%), chronic headaches (26.4%), and
epilepsy (8.5%), followed by pain syndromes (7.5%), stroke (6.6%) and tremors/Parkinson disease (3.8%). The
crude prevalence rates of these disorders (95% CI) were 14.3% (8.5–24.1); 13.3% (7.7–22.8); 33.7% (23.9–47.4) for
stroke, epilepsy and peripheral neuropathy respectively. Peripheral neuropathy followed by chronic headaches had
the highest estimated incidence/1000 years. Stroke had an estimated incidence of 3.6 new cases with 95% CI of
(2.1–6.1)/1000 years.
Conclusion: Peripheral neuropathy, chronic headaches and epilepsy disorders are major causes of morbidity in
Sub-Saharan settings. There is an urgent need of more robust and powered studies to determine the incidence of
these diseases.
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Background
Neurological diseases contribute significantly to morbid-
ity and mortality worldwide. Globally, stroke is the
second leading cause of death after ischemic heart
disease [1, 2]. The burden of neurological conditions in
sub-Saharan Africa has been increasing over the years
[3]. Neurological disorders contributed to 92 million
disability-adjusted life-years (DALY) in 2005 and were
projected to 103 million in 2030 worldwide [4]. The
annual incidence of stroke has been estimated to be 316
per 100 000, and a prevalence of up to 315 per 100 000
with a three-year fatality of up to 84% in Africa [5]. The
yearly age-adjusted rates of stroke per 100,000 people in
the developing countries, the 15 to 64 age group aver-
aged 49 per 100,000, four times the rates in developed
countries. To date, most data on mortality have been
hospital-based, although the majority of stroke deaths in
the region are thought to occur at home [6].
Epidemiological data plays an important role in identi-
fication of disease occurrence and patterns as well as
associated risk factors and etiology [7, 8]. The World
Health Organization estimates that by the year 2030,
80% of all strokes will occur in low and middle income
countries like Uganda [9] which are still battling with
the scourge of communicable diseases like HIV/AIDS,
malaria and tuberculosis. It is also clear that, as econ-
omies improve in resource-limited areas of the world,
with associated changes in lifestyle, diet and environ-
ment, diseases more often associated with the Western
world (such as stroke) are on the rise.
Neurological diseases may cause disproportionate
burden in sub-Saharan Africa compared to developed
countries. In Africa, stroke occurs in younger age-
groups (30–69 years), and the resultant economic im-
pact is felt on country’s health system as well as the loss
of income and production of those affected either
directly or indirectly by the disease [10]. Epilepsy is a
much more frequent cause of death in Sub-Saharan
Africa than in developed countries [11]. A community-
based study done in Ethiopia revealed that 6.3% of
people with epilepsy had died over a two-year period
and one-third in 20 years [12]. In Africa, epilepsy mor-
tality is primarily due to poorly controlled seizures and
from accidents in addition to the sudden unexpected
death in epilepsy (SUDEP) that is known throughout the
world [11]. It is worth noting that these frequencies are
likely underestimates, particularly in resource-limited
areas of the world because of poor health reporting and
limited health infrastructure. In spite of many Africans
dying prematurely from neurological diseases, an epi-
demiological transition is being observed with an increase
in longevity and increase in those who develop neuro-
logical diseases that more commonly present in later-life
[13]. This transition and an increasing prevalence of
neurological diseases in sub-Saharan Africa pose a major
threat to livelihood and economic development.
Unfortunately, there is little epidemiological data in
neurological conditions in many Sub-Saharan African
countries. No adequate research has been done to
determine the prevalence or incidence of neurological
diseases within the Ugandan population. Therefore, our
study objective was to determine the prevalence of
neurological diseases in urban and rural populations of
Mukono, a region surrounding the Ugandan capital of
Kampala. This study serves as a starting point to inform
policy on the prevalence and incidence of neurological
diseases, and also serve as a baseline for planning and
care for neurological disorders in Uganda.
Methods
Study design
This was a cross-sectional study.
Study site and settings
The study was conducted in Mukono district which lies in
the central region of Uganda. It shares boundaries with the
districts of Buikwe in the East; Kayunga along River
Sezibwa in the North; Luwero in the North West; Kampala
and Wakiso in the South-West; and Lake Victoria and
Tanzania in the South. The district headquarters are
situated in Mukono town, 21 kms East of Kampala city.
The 2002 population census projected Mukono’s popula-
tion to be 536,400 people with a population density of 495
people per km2. Currently, the population under 18 years
is 443,946; the youth (18–30) are 175,708, while those aged
60 years and above are 38,975 [14]. Mukono district has
two health centre IV, 13 health centre III, 21 health centre
II, 85 private clinics, 320 registered drug shops, 25 domi-
ciliary maternity units and two private not for profit
religious based hospitals.
Using a cross sectional community based survey, we
randomly selected 3000 adults, aiming at interviewing at
least one adult per household selected. About 1500 sub-
jects from two sub-counties of Mukono Town Council
and Kojja over a 6 months period from June 2014 –
December 2014 were enrolled for this study. Mukono
Town Council and Kojja sub-counties represented urban
and rural populations respectively. This classification
was based on information from the Mukono district ad-
ministration and the current level of urbanization. Dur-
ing this community survey, 3000 adults were screened
from the list of households randomly generated from a
census database at each sub – county. The stepwise ap-
proach was followed as shown below; Administration of
a questionnaire, physical measurements such as weight,
height, waist hip ratio, blood pressure and neurological
examination and laboratory measurements; including
fasting blood glucose and lipid parameters [15].
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Sample size calculations
We considered a sample of 3000 participants, larger
than 2232 which was used by Dewhurst et al. (2012)
[16]. A larger sample size was considered to account for
uncertainty of non-response.
We therefore selected 3000 study participants (1500
rural and 1500 urban) for this survey using multi-stage
sampling procedure at the sub-county, parish and village




A village was targeted for recruitment once their local
council agreed to participate and community meetings
explaining study activities had taken place. The next step of
securing engagement with the study involved direct partici-
pant candidate notification, which happened a week before
arrival of the survey teams. The notification procedures
were carried out to ensure maximum participant availability
when the survey teams arrived, and also provide an
opportunity to answer any questions about the study.
Written informed consent from all study participants
was obtained before enrolment, including the use of reli-
able intermediaries as appropriate to ensure that the im-
plications of participation were fully understood. Eligible
adult participants and emancipated minor participants
also provided informed consent. Emancipated minors are
defined by the Ugandan National guidelines for Research
involving human as Research participants as individuals
below the age of majority, who are pregnant, married,
have a child or provide for their own livelihood [17].
Participant recruitment
Our study used the modified version of a survey question-
naire developed by the World Health Organization (WHO)
protocol for Epidemiological Neurological Disorders in
developing countries which has been used by earlier studies
[16, 18]. The sensitivity of the screening instrument ranges
from 96% and specificity was 86% [19]. The interviewers
were trained by neurologists in the research team.
Survey screening (study phase I)
At the community level, house-to- house screening of
residents was undertaken by trained interviewers. Dur-
ing the survey, only residential buildings were surveyed
and demographic plus other relevant clinical information
were obtained from the participants or household
member such as a parent or first degree relative, if the
person was unavailable or unable to respond appro-
priately to the questions asked.
All adult members of a household were eligible to take
part in the survey, however only one adult member of
the household member was selected to participate in the
survey. If he/she agreed in principle to take part in the
survey, a written informed consent was then obtained
and the participant given a study number. The selected
household member then would be requested to respond
to the survey questionnaire. If an individual declined to
participate then they would be replaced by other eligible
household member where possible or the next house-
hold is approached (Fig. 1).
Neurological examination (study phase II)
After the survey, study participants who were responded
affirmatively for any neurological disorder in the screen-
ing form were scheduled for a complete neurological
examination performed by a neurologist on a given day
at the local health center nearby. A clinical examination
questionnaire included additional pain, neuropathy, epi-
lepsy, headache, Parkinson’s disease and stroke-specific
questions to further validate the diagnosis. Disease
condition duration, symptoms, drug history and risk
factors were also assessed.
Diagnostic criteria
The burden of the neurological disorders was determined
as point prevalence, and defined as the proportion of
Fig. 1 Showing the study flow diagram
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patients who had a specific neurological diagnosis at the
day of contact with the study researchers. The diagnoses
were based on the WHO classifications of diseases [20].
The diagnoses of these diseases were considered definite if
(1) Other physicians had previously the neurological
condition and the study neurologist concurred with the
diagnosis and (2) the study neurologist found presenting
sequelae consistent with such a diagnosis.
Collection of survey questionnaire data
After obtaining informed consent, the survey team
collected the required information using a structured
pre-tested questionnaire. The questionnaire was admin-
istered by face to face personal interviews at a research
clinic or selected area, ensuring a setting that provided
maximum privacy to conduct the interview, demo-
graphic data (age, sex, address), dietary, tobacco and al-
cohol consumption and medical history, socioeconomic
status, family history and symptoms of neurological dis-
ease including chronic headaches, seizures, limb weak-
ness etc. were assessed.
Neurological assessments
The screening instrument for neurological disorders was
adopted from a previous survey conducted in Tanzania
having a sensitivity of 87.8% and specificity of 94.9% [16].
For all subjects who responded yes to the survey screening
questionnaire an appointment for a neurological exam
was scheduled within two days (Additional file 1). A full
neurological history and examination was performed by a
team of neurologists who would confirm or exclude a
neurological disease. The individual results of the screen-
ing questionnaire, neurological history and examination
were validated with a neurologist (KM, MNK, ED) were
appropriate.
Ethical considerations
Ethical approval for the study was obtained from Makerere
University College of Health Sciences’ School of Medicine
review board and ethics committee Ref number 2013–145
and Uganda National Council of Science and Technology
Ref Number. HS1551. Written informed consent was
obtained before enrolling the participants into the study.
Statistical analysis
When dealing with binary outcomes from cross-sectional
studies, several alternatives to logistic regression have
been proposed to estimate prevalence, prevalence ratio,
incidence rate and incidence rate ratio. Some of the alter-
native models include log-binomial regression, Poisson
regression [21] and complementary log-log model, where
the link function is log(− log(1 -π)) and the distribution is
binomial [22]. In this paper we applied the Poisson model
to estimate the prevalence and prevalence ratios, and
complementary log-log model to estimate incidence and
incidence rates. We fitted these models to each health
condition (coded 0 if absent and 1 if present). We used
only the intercept models to estimate both the prevalence
and incidence rate. Later, we included covariates like sex
into the models to estimate the ratios. For the comple-
mentary log-log model, the logarithm of the individual’s
age (a) in year was set as an offset variable. The incidence
of a particular condition was then estimated by exponenti-
ation of the model coefficient. Since log(a), expressed as
years of age, was included in the model as offset for each
condition, the exponential of the constant in each case, is
the estimated annual incidence rate. The estimates per
100,000 years rates were obtained simply by multiplying
the annual incidence rates by 100,000. The latter rates
were presented for comparison purposes with prior stud-
ies. All the analyses were done in STATA version 12 (Stata
Corporation, College Station, TX, USA).
Results
Baseline demographics
A total of 3000 subjects were screened from 3858 house-
holds, with 50.3% (1510/3000) from the rural setting. Out
of the participants screened, 67.4% were female, with a
median age (IQR) of 33 (26–47) years. (See Table 1)
Majority of the study participants 84.9% (2547/3000) were
Baganda by tribe, which is the predominant tribe within
the study settings.
Table 1 Distribution of the baseline characteristics of the
screened patients
Baseline characteristic Total N (%)
Residence Urban 3000 1490 (49.7)
Rural 3000 1510 (50.3)
Gender Male 2964 966 (32.6)
Female 2964 1998 (67.4)
Mean (SD)
Blood pressure: Systolic (A/) 2948 132.8 (22.3)
Blood pressure: Diastolic: (/B) 2948 81.0 (20.0)
Pulse 2947 80.2 (14.9)
Weight in Kg 2925 64.3 (14.9)
Median (IQR)
Age in years 2936 33 (26–47)
Height in cm 2938 161.3 (156–167)
Body Mass Index (BMI) 2915 23.4 (20.8 – 27.4)
BMI classifications
Under weight 2915 218 (7.5)
Normal weight 2915 1555 (53.3)
Over weight 2915 702 (24.1)
Obese 2915 440 (15.1)
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Response to the screening questionnaire
Among the study participants, 45.1% (1352/3000)
responded yes to one or more of the study questions in
the screening questionnaire. The most common re-
sponse was having persistent loss of sensation (numb-
ness) in arms or legs or hands or feet not due to cold
weather 66.2% (895/1352). The least common response
was having polio that resulted in long term problems/
disability contributing 1.0% (14/1352). See Table 2.
Among the 1352 study participants, 5.0% (68) reported
that they had been told that they have a neurological
disorder. However, only 38.2% (26/68) could specify the
type of the neurological disorder and of these 22.2%
(15/68) noted that the neurological disorder was present
at the time of the survey. Stroke and epilepsy were the
most common accounting for 40 and 31.3% respectively.
Other disease conditions specified included spinal cord
problems, mental disorder and cerebral palsy with 2
(13.3), 1 (6.7) and 1 (6.7%) respectively.
Prevalence of neurological disorders among the study
participants
The highest prevalence of diagnoses made within the study
group in descending order were; Peripheral neuropathy,
chronic headaches, stroke epilepsy, pain syndromes and
tremors (Table 3). Out of the 1352 respondents to the
screening questionnaire, a total of 98 neurological cases
were observed in this group of participants who turned up
at the health facilities on the scheduled days. Peripheral
neuropathy had 33 cases, chronic headaches 20 cases,
stroke 14 cases, epilepsy 13 cases, pain syndromes 10 and
tremors had 8 cases. Among the chronic headaches, cluster
headaches had the lowest crude prevalence rate of 1% with
95% CI of 0.1–7.2.
Distribution of neurological diseases according to age
and sex among the study participants
Nearly, two thirds of the study participants were female,
77.6% (76/98) and overall they were diagnosed with more
diseases than males. Among those diagnosed with the
following neurological disorders; pain syndromes, periph-
eral neuropathy, epilepsy, chronic headaches, and stroke,
70, 78.8, 69.2, 80 and 85.7% respectively were female.
Migraine headaches were the most common type of
chronic headache contributing 65%, with 85% of the
sufferers being female. Stroke was more prevalent among
females with prevalence of 15.8% compared to 9.1% for
males. Females also had a higher prevalence (95% CI) of
peripheral neuropathy 34.2% (23.3–50.2) and migraine
headaches 14.5% (8.0–26.1) compared to males with
31.8% (15.2–66.7) and 9.1% (2.2–36.3) respectively. Male
had a higher prevalence for epilepsy, pain syndromes,
tremors and tension headaches (See Table 4).
Table 2 Distribution of the screened patients who responded
yes to one or more of the study questions in the screening
questionnaire
(N = 1352) Yes N (%)
Have Persistent loss of sensation (numbness)
in arms or legs or hands or feet that is not
just due to cold or pain
895 (66.2)
Have severe recurrent headaches that
stop one from doing normal daily activities
434 (32.1)
Have persistent weakness in any arms or
legs, one side or both sides of the face
301 (22.3)
Have current weakness down one side
of the body
267 (19.8)
Have problem opening or closing eye (s)
that cannot be explained by tiredness or
any other reason.
203 (15.0)
Have problem balancing on legs or difficulty
walking that is due to pain or injury
163 (12.1)
Have recurrent attacks of violent shaking in
one arm and/or one leg and/or in one side
of the face that are not just brief tremors of
the hands after working hard
108 (8.0)
Have arms or legs shake multiple times every
day not due to alcohol or working hard
88 (6.5)
Have recurrent attacks involving falling with
loss of consciousness and violent shaking
of the limbs
87 (6.4)
Have shaking of hand, leg or trunk which
cannot be controlled
85 (6.3)
Have neurological disorder (a disorder
affecting brain, spinal cord or nerves)
68 (5.0)
Shuffles feet and takes small steps when
walking not just because of pain
58 (4.3)
Have persistent weakness of one or both
sides of face present
49 (3.6)
Ever had a stroke that resulted in long term
problems/disability
47 (3.5)
Walk like one who has taken alcohol yet not 46 (3.4)
Have recurrent short attacks of severe shock
like pain affecting one side of the face
40 (3.0)
Have persistent problems pronouncing words
not just because of having a sore throat or
mouth that affects him/her most of the time
36 (2.7)
Have persistent problems with coordination
such as stirring a cup of tea with a spoon or
buttoning clothes that is not due to pain in
hands or arms or because of drinking alcohol
25 (1.9)
Have head shake all or most of the time such
that it is visible
21 (1.6)
Have been told to have epilepsy or epileptic
fits or seizures
21 (1.6)
Have been told to have Parkinson’s disease 19 (1.4)
Have ever had polio that resulted in long
term problems/disability
14 (1.0)
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Age distribution and estimated incidence according to
the diseases
The subjects with epilepsy were younger with a median
age in years (IQR) of 27 (22–32) compared to stroke
subjects with median age of 57.5 (45–75) years. The me-
dian ages for peripheral neuropathy and pain syndromes
were similar at 45 years. Among those with chronic
headaches, the median age for migraine, tension and
cluster was 40, 46.5 and 27 years respectively (Table 5).
Peripheral neuropathy followed by chronic headaches
had the highest estimated incidence/1000 years. Stroke
had an estimated incidence of 3.6 new cases with 95%
CI of (2.1–6.1)/1000 years (Table 6). There were no dif-
ferences among those who were normal, underweight,
overweight and obese study participants (Table 7).
Discussion
Sub-Saharan Africa is experiencing a dramatic increase in
non-communicable diseases (NCDs) [23] including neuro-
logical conditions. Determining the distribution of neuro-
logical disorders in sub-Saharan Africa is needed to enable
health care planning. There is a dearth of information on
incidence and morbidity of non-communicable diseases in
sub-Saharan Africa, including Uganda.
This is the first neurological disorders survey done in
Uganda. The overall point prevalence of neurological
diseases was 3.3%. The crude prevalence of stroke was
14.3%; (95% CI:8.5–24.1). This is within the worldwide
prevalence of stroke which varies between 4 and 20 per
1000 population [24, 25]. The estimated incidence
(95% CI) for stroke was 360 (210–610) per 100,000 years.
This is higher than figures reported from Nigeria, 134/
100,000 [26] but lower than settings such as 424/100,000
in Bombay, India, [27] 461/100,000 in Cotonou, Benin
[28], and 620/100,000 in China [29]. Our observed trend
of increasing stroke prevalence among women differs
from earlier studies [25, 30, 31]. Plausible reasons for this
observation include the fact that more women seek health
care compared to men [32, 33]. Reports from hospital-
based studies still show that more than half of stroke
subjects admitted are female.
The crude prevalence of epilepsy in our survey was
13.3% (95% CI of 7.7–22.8) with an incidence rate of
320/100,000 years (95% CI of 180–540) in Mukono
district. This is lower than rates reported in Egypt (550/
100,000), UK (400/100,000) and India (883/100,000).
However, this is higher than an earlier study conducted
in Uganda which reported an overall crude incidence
Table 3 Crude prevalence of diagnosed diseases among the







Stroke 14 14.3 (8.5–24.1)
Epilepsy 13 13.3 (7.7–22.8)
Pain syndrome 10 10.2 (5.5–19.0)
Peripheral neuropathy 33 33.7 (23.9–47.4)
Tremors 8 8.2 (4.1–16.3)
Chronic headaches 20 20.4 (13.2–31.6)
Table 4 Prevalence of diagnosed diseases among the study population, adjusted for sex (male = 22, female = 76)
Diagnosed diseases Sex Number of observed cases Prevalence % (95% CI) Prevalence ratio (95% CI)
Stroke Male 2 9.1 (2.3–36.3) Reference
Female 12 15.8 (9.0–27.8) 1.7 (0.4–7.8)
Epilepsy Male 4 18.2 (6.8–48.4) Reference
Female 9 11.8 (6.2–22.8) 0.7 (0.2–2.1)
Pain syndrome Male 3 13.6 (4.4–42.3) Reference
Female 7 9.2 (4.4–19.3) 0.7 (0.2–2.6)
Peripheral neuropathy Male 7 31.8 (15.2–66.7) Reference
Female 26 34.2 (23.3–50.2) 1.1 (0.5–2.5)
Tremors Male 2 9.1 (2.2–36.3) Reference
Female 6 7.9 (3.5–17.6) 0.9 (0.2–4.3)
Chronic headaches Male 4 18.2 (6.8–48.4) Reference
Female 16 21.1 (12.9–34.4) 1.2 (0.4–3.5)
Table 5 Median age for diagnosed diseases among the study
population (N = 98)
Diagnosed diseases Median age (IQR)
Stroke 57.5 (45–75)
Epilepsy 27 (22–32)
Pain syndrome 45 (27–60)
Peripheral neuropathy 45 (31–56)
Tremors 41.5 (27–65.5)
Chronic headaches 40.0 (26.5–52.5)
***un-estimable due to 1 case observed
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rate of 215 per 100000 person-years, (age-adjusted: 156
per 100000 person-years). People with epilepsy in our
survey were not routinely attending and receiving anti-
epileptic therapy for their seizure control. The treatment
gap in our setting appears due to problems with medica-
tion access, lack of follow-up, and epilepsy stigma.
The overall prevalence of chronic primary headaches
was 18.4% (95% CI), this is slightly lower than earlier
studies in similar regions in Africa. A higher prevalence
was recorded in Zambia (72%) (gender- and habitation-
adjusted 61.6%) [34] whereas, lower prevalence was
reported in Ethiopia (21.6%) [35] and Tanzania (23.1%)
[36]. The differences in the prevalence could be attrib-
uted to different methodologies used, as well as cultural
and population characteristics of the studied patients.
Female predominance is an almost consistent finding in
many other studies, which reflects the fact that primary
headaches are more common in women [37].
Chronic headaches may remain under-detected by
household members and even by general practitioners.
There are little or no efforts to education communities
on chronic headaches in our settings. However, the avail-
ability of pain relievers as over-the-counter medicines
may be playing a role in reducing headache burden
within communities. The majority of those diagnosed
with chronic primary headaches had never sought
formal medical care for their medical conditions.
Table 6 Incidence of diagnosed diseases among the study
population adjusted for age using log (age) as an offset variable
(N = 98)
Diagnosed diseases Incidence (95% CI) per Incidence (95% CI) per
1000 yearsa 100, 000 yearsb
Stroke 3.6 (2.1–6.1) 360 (210–610)
Epilepsy 3.2 (1.8–5.4) 320 (180–540)
Pain syndrome 2.4 (1.3–4.5) 240 (130–450)
Peripheral neuropathy 9.4 (6.6–13.2) 940 (660–1320)
Tremors 1.9 (0.9–3.9) 190 (90–390)
Chronic headaches 5.1 (3.3–8.0) 510 (330–800)
aEstimated number of new cases per 1000 years
bEstimated number of new cases per 100,000 years
Table 7 Prevalence of diagnosed diseases among the study population, adjusted for BMI (underweight = 11, normal = 49, over
weight = 24, obese = 12)
Diagnosed diseases MBI categories Number observed cases Prevalence % (95% CI) Prevalence ratio 95% CI)
Stroke Normal 7 14.3 (6.8–30.0) Reference
Under weight 1 9.1 (1.2–64.5) 0.6 (0.1–5.2)
Over weight 2 8.3 (2.1–33.3) 0.6 (0.1–2.8)
Obese 3 25.0 (8.1–77.5) 1.8 (0.5–6.8)
Epilepsy Normal 7 14.3 (6.8–30.0) Reference
Under weight 1 9.1 (1.2–64.5) 0.6 (0.1–5.2)
Over weight 5 20.8 (8.7–50.1) 1.5 (0.5–4.6)
Obese 0 0 0
Pain syndrome Normal 4 8.1 (3.1–21.8) Reference
Under weight 1 9.1 (1.2–64.5) 1.1 (0.1–10.0)
Over weight 2 8.3 (2.1–33.3) 1.0 (0.2–5.6)
Obese 3 25.0 (8.1–77.5) 3.1 (0.7–13.7)
Peripheral neuropathy Normal 18 36.7 (23.1–58.3) Reference
Under weight 3 27.3 (8.8–84.6) 0.7 (0.2–2.5)
Over weight 6 25.0 (11.2–55.6) 0.7 (0.3–1.7)
Obese 5 41.7 (17.3–100) 1.1 (0.4–3.1)
Tremors Normal 4 8.2 (3.1–21.8) Reference
Under weight 2 18.2 (4.5–72.7) 2.2 (0.4–12.2)
Over weight 2 8.3 (2.1–33.3) 1.0 (0.2–5.6)
Obese 0 0 0
Chronic headaches Normal 6 18.4 (9.6–35.3) Reference
Under weight 1 27.3 (8.8–84.6) 1.5 (0.4–5.5)
Over weight 5 29.2 (13.9–61.2) 1.6 (0.6–4.3)
Obese 1 8.3 (1.2–59.2) 0.5 (0.1–3.6)
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Few studies have explored the presence of peripheral
neuropathy within community populations. Majority of
studies have explored neuropathy in subjects who are
diabetic or HIV infected. Our study reports a crude preva-
lence (95% CI) of 33.7 (23.9–47.4). This was based on
symptoms and clinical examination with a monofilament
no objective assessment with electro-neuromyography
was performed. This may over estimate the prevalence of
peripheral neuropathy in our settings. Focused studies
utilizing the electroneuromyography are needed to explore
this. However, our prevalence rates are similar to the
reported prevalence among HIV infected cohorts in a
range of 35–52% [38–41]. In this study we did not
exclude HIV infected individuals and this might have
affected the results. Studies among HIV infected cohorts
have reported a significant association of low serum albu-
min levels with presence of peripheral neuropathy symp-
toms in HIV-infected individuals [40, 42]. This study was
conducted in rural and urban settings; it’s probable that
low protein diet in our communities may have a role in
this high prevalence and further studies are needed to
explore this.
Majority of the study participants were Baganda by
tribe, this is the predominant ethnic tribe in Uganda,
though contributing about 17% of the total popula-
tion of Uganda. Therefore these results may be inter-
preted with caution as they might not represent the
true findings in other ethnic tribes within Uganda.
National wide, multi-ethnic studies may be needed to
address this.
However, there was a low participation of males in this
study, probably because males have a poor health seek-
ing behavior [43] and also being the main bread winners
for their households might have been away during the
time of the conduct of the survey.
Strengths and limitations
The studied population is representative of the general
population, including the rural and urban settings in
Uganda. Other strengths include use of a standardised
instrument to evaluate the presence of neurological
disorders and neurological examination by a team of
neurologists. Limitations include cross-sectional design
and the fact that incidence is better estimated by
prospective studies. Not all subjects who respondents to
the study questionnaire followed-up to the health facil-
ities for medical evaluation, this might have led to
under-reporting of diseases. There was a low participa-
tion of males and this might not reflect a true prevalence
among this population. The study enrolled only adults
and excluded those aged less than 18 years, further stud-
ies are needed to describe the prevalence of neurological
diseases in children.
Conclusions
Neurological diseases identified in this large Ugandan
survey are similar to those in the majority of tropical
countries. Stroke, epilepsy, chronic headaches and peri-
pheral nerve disorders were the most frequent neuro-
logical conditions. Further prospective studies need to be
conducted to determine the true incidence of these
diseases in our settings.
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